Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience

Objective. To evaluate, in three Spanish tertiary referral centres, the short-term safety and efficacy of golimumab (GLM) for treatment of immune-mediated uveitis resistant to previous immunosuppressive therapy. Methods. Nonrandomized retrospective interventional case series. Thirteen patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordero-Coma, Miguel, Calvo-Río, Vanesa, Adán, Alfredo, Blanco, Ricardo, Álvarez-Castro, Carolina, Mesquida, Marina, Calleja, Sara, González-Gay, Miguel A., Ruíz de Morales, José G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058145/
https://www.ncbi.nlm.nih.gov/pubmed/24976689
http://dx.doi.org/10.1155/2014/717598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058145/
https://www.ncbi.nlm.nih.gov/pubmed/24976689
http://dx.doi.org/10.1155/2014/717598

Ejemplares similares